Original Study| Volume 19, ISSUE 7, P619-622.e1, July 2018

The Cost-Effectiveness of Using PARO, a Therapeutic Robotic Seal, to Reduce Agitation and Medication Use in Dementia: Findings from a Cluster–Randomized Controlled Trial

Published:January 09, 2018DOI:



      To examine the within-trial costs and cost-effectiveness of using PARO, compared with a plush toy and usual care, for reducing agitation and medication use in people with dementia in long-term care.


      An economic evaluation, nested within a cluster–randomized controlled trial.


      Twenty-eight facilities in South-East Queensland, Australia.


      A total of 415 residents, all aged 60 years or older, with documented diagnoses of dementia.


      Facilities were randomized to 1 of 3 groups: PARO (individual, nonfacilitated 15-minute sessions, 3 afternoons per week for 10 weeks); plush toy (as per PARO but with artificial intelligence disabled); and usual care.


      The incremental cost per Cohen-Mansfield Agitation Inventory–Short Form (CMAI-SF) point averted from a provider's perspective. Australian New Zealand Clinical Trials Registry (BLINDED FOR REVIEW).


      For the within-trial costs, the PARO group was $50.47 more expensive per resident compared with usual care, whereas the plush toy group was $37.26 more expensive than usual care. There were no statistically significant between-group differences in agitation levels after the 10-week intervention. The point estimates of the incremental cost-effectiveness ratios were $13.01 for PARO and $12.85 for plush toy per CMAI-SF point averted relative to usual care.


      The plush toy used in this study offered marginally greater value for money than PARO in improving agitation. However, these costs are much lower than values estimated for psychosocial group activities and sensory interventions, suggesting that both a plush toy and the PARO are cost-effective psychosocial treatment options for agitation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Livingston G.
        • Kelly L.
        • Lewis-Holmes E.
        • et al.
        A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.
        Health Technol Assess. 2014; 18: 488-494
        • Rice D.
        • Fillit H.
        • Max W.
        • et al.
        Prevalence, costs, and treatment of Alzheimer's disease and related dementia: A managed care perspective.
        Am J Manag Care. 2001; 7: 809-818
        • Kaplan D.B.
        • Berkman B.
        Dementia care: A global concern and social work challenge.
        International Social Work. 2011; 54: 361-373
        • Australian Institute of Health and Welfare
        Dementia in Australia. Cat. no. AGE 70.
        AIHW, Canberra2012
        • Kong E.H.
        • Evans L.K.
        • Guevara J.P.
        Nonpharmacological intervention for agitation in dementia: A systematic review and meta-analysis.
        Aging Ment Health. 2009; 13: 512-520
        • Spenceley S.
        • Witcher C.S.
        • Hagen B.
        • et al.
        Sources of moral distress for nursing staff providing care to residents with dementia.
        Dementia (London). 2017; 16: 815-834
        • Kales H.C.
        • Gitlin L.N.
        • Lyketsos C.G.
        Assessment and management of behavioral and psychological symptoms of dementia.
        BMJ. 2015; 350: h369
        • National Institute for Health and Care Excellence
        Dementia: Supporting people with dementia and their carers in health and social care.
        (Available at:)
        Date accessed: March 15, 2016
        • Joranson N.
        • Pedersen I.
        • Rokstad A.M.
        • et al.
        Effects on symptoms of agitation and depression in persons with dementia participating in robot-assisted activity: A cluster-randomized controlled trial.
        J Am Med Dir Assoc. 2015; 16: 867-873
        • Moyle W.
        • Cooke M.
        • Beattie E.
        • et al.
        Exploring the effect of companion robots on emotional expression in older adults with dementia: a pilot randomized controlled trial.
        J Gerontol Nurs. 2013; 39: 46-53
        • Petersen S.
        • Houston S.
        • Qin H.
        • et al.
        The utilization of robotic pets in dementia care.
        J Alzheimers Dis. 2017; 55: 569-574
        • Takayanagi K.
        • Kirita T.
        • Shibata T.
        Comparison of verbal and emotional responses of elderly people with mild/moderate dementia and those with severe dementia in responses to seal robot, PARO.
        Front Aging Neurosci. 2014; 6: 257
        • Thodberg K.
        • Sørensen L.U.
        • Videbech P.B.
        • et al.
        Behavioral responses of nursing home residents to visits from a person with a dog, a robot seal or a toy cat.
        Anthrozoös. 2016; 29: 107-121
        • Bemelmans R.
        • Gelderblom G.J.
        • Jonker P.
        • et al.
        Socially assistive robots in elderly care: A systematic review into effects and effectiveness.
        J Am Med Dir Assoc. 2012; 13: 114-120
        • Moyle W.
        • Jones C.
        • Murfield J.
        • et al.
        Use of a robotic seal as a therapeutic tool to improve dementia symptoms: a cluster-randomised controlled trial.
        J Am Med Direct Assoc. 2017; 18: 766-773
        • Werner P.
        • Cohen-Mansfield J.
        • Koroknay V.
        • et al.
        The impact of a restraint-reduction program on nursing home residents.
        Geriatr Nurs. 1994; 15: 142-146
        • Moyle W.
        • Beattie E.
        • Draper B.
        • et al.
        Effect of an interactive therapeutic robotic animal on engagement, mood states, agitation and psychotrophic drug use in people with dementia. a cluster randomised controlled trial protocol.
        BMJ Open. 2015; 5: e009097
        • Moyle W.
        • Bramble M.
        • Jones C.
        • Murfield J.
        Care staff perceptions of a social robot called paro and a look-alike plush toy: a descriptive qualitative approach.
        Aging Ment Health. 2016; : 1-6
        • Sansoni J.
        • Marosszeky N.
        • Jeon Y.-H.
        • et al.
        Final report: Dementia outcomes measurement suite project.
        Centre for Health Service Development, University of Wollongong, Wollongong, NSW, Australia2007
        • Department of Health
        Pharmaceutical Benefits Scheme (PBS).
        (Available at:)
        Date accessed: February 23, 2016
        • Chenoweth L.
        • King M.T.
        • Jeon Y.H.
        • et al.
        Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: A cluster-randomised trial.
        Lancet Neurol. 2009; 8 (Accessed February 23, 2016.): 317-325
        • Mintzer J.E.
        • Colenda C.
        • Waid L.R.
        • et al.
        Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients.
        Psychiatr Serv. 1997; 48: 1435-1439
        • Norman R.
        • Haas M.
        • Chenoweth L.
        • et al.
        Dementia care mapping and patient-centred care in australian residential homes: An economic evaluation of the care study.
        Centre for Health Economics Research and Evaluation, University of Technology, Sydney, Sydney, NSW, Australia2008
        • American Geriatrics Society
        2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults.
        J Am Geriatr Soc. 2015; 63: 2227-2246
        • Moyle W.
        • El Saifi N.
        • Draper B.
        • et al.
        Pharmacotherapy of persons with dementia in long-term care in australia: a descriptive audit of central nervous system medications.
        Curr Drug Saf. 2017 Feb 9; ([Epub ahead of print])